Recent Advances in Gynecological Malignancies: Focus on ASCO 2023

Oncol Ther. 2023 Dec;11(4):397-409. doi: 10.1007/s40487-023-00244-5. Epub 2023 Sep 15.

Olga Bodriagova¹, Rebecca Ann Previs^{2

3}, Lydia Gaba⁴, Abhishek Shankar⁵, Laura Vidal¹, Kamal S Saini^{6

7}

¹ Fortrea Inc., 8, Moore Drive, Durham, NC, 27709, USA.
² Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, USA.
³ Labcorp Oncology, Durham, USA.
⁴ Hospital Clinic de Barcelona, Barcelona, Spain.
⁵ Department of Radiation Oncology, Dr. BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
⁶ Fortrea Inc., 8, Moore Drive, Durham, NC, 27709, USA. Kamalveer.saini@fortrea.com.
⁷ Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Kamalveer.saini@fortrea.com.

No abstract available

Keywords: ADC; ASCO; Cervical cancer; Endometrial cancer; Gynecology cancer; Immunotherapy; Ovarian cancer.

Publication types